In this study, we found that HAMP expression was significantly upregulated and consistently correlated with clinicopathological parameters in ccRCC patients, including cancer grade, tumor stage, lymph node metastasis, distal metastasis, molecularly classified subgroups, disease progression, and patient survival. Here, HAMP is linked to cancer.